BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4694374)

  • 1. Direct and systemic effects of hexobendine on renal function.
    Cho YW; Pearson JE; Saito S
    Arch Int Pharmacodyn Ther; 1973 Apr; 202(2):402-14. PubMed ID: 4694374
    [No Abstract]   [Full Text] [Related]  

  • 2. Direct and systemic effects of guanethidine on renal function.
    Williams RL; Maines JE; Pearson JE
    J Pharmacol Exp Ther; 1971 Apr; 177(1):69-77. PubMed ID: 4398048
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic and coronary hemodynamic effects of hexobendine and its interaction with adenosine and aminophylline.
    Hansing CE; Folts JD; Afonso S; Rowe GG
    J Pharmacol Exp Ther; 1972 Jun; 181(3):498-511. PubMed ID: 5033015
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of adenosine 3',5'-cyclic monophosphate (cyclic AMP) on the circulatory system and renal function].
    Kishimoto T; Shimizu H
    Nihon Yakurigaku Zasshi; 1967 Nov; 63(6):461-71. PubMed ID: 4298371
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopamine in man: cardiorenal hemodynamics in normotensive patients with heart disease.
    Rosenblum R; Tai AR; Lawson D
    J Pharmacol Exp Ther; 1972 Nov; 183(2):256-63. PubMed ID: 5083544
    [No Abstract]   [Full Text] [Related]  

  • 6. Some toxicological aspects of a nicotinamide-methylaminopyrazolone (Ra 101).
    Tubaro E; Bulgini MJ; Del Grande P; Monai A
    Arzneimittelforschung; 1970 Aug; 20(8):1024-9. PubMed ID: 4394829
    [No Abstract]   [Full Text] [Related]  

  • 7. Cerebral and coronary vascular effects of a symmetrical N,N'-disubstituted hexahydrodiazepine.
    Buyniski JP; Losada M; Bierwagen ME; Gardier RW
    J Pharmacol Exp Ther; 1972 Jun; 181(3):522-8. PubMed ID: 5033017
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of dilazep on cardiac function, coronary circulation and myocardial energy metabolism].
    Katano Y; Takeda K; Otorii T; Horii D; Imai S
    Nihon Yakurigaku Zasshi; 1974 Mar; 70(2):305-14. PubMed ID: 4858949
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs.
    Vatner SF; McRitchie RJ; Braunwald E
    J Clin Invest; 1974 May; 53(5):1265-73. PubMed ID: 4825224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sarafotoxin S6c on antidiuresis and norepinephrine overflow induced by stimulation of renal nerves in anesthetized dogs.
    Matsuo G; Matsumura Y; Tadano K; Morimoto S
    J Pharmacol Exp Ther; 1997 Feb; 280(2):905-10. PubMed ID: 9023305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of renal arterial infusion of cholinomimetic agents on renal function.
    Cohen MR; Carter MK
    Arch Int Pharmacodyn Ther; 1967 Dec; 170(2):473-84. PubMed ID: 6076596
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic and hemodynamic effects of oral hexobendine in dogs.
    Hansing CE; Folts JD; Afonso S; Rowe GG
    Arzneimittelforschung; 1972 Feb; 22(2):398-402. PubMed ID: 5067494
    [No Abstract]   [Full Text] [Related]  

  • 13. Dose response relation of the renal effects of PGA1, PGE2, and PGF-2alpha--in dogs.
    Fülgraff G; Brandenbusch G; Heintze K
    Prostaglandins; 1974 Oct; 8(1):21-30. PubMed ID: 4457955
    [No Abstract]   [Full Text] [Related]  

  • 14. Some acute hemodynamic effects of large doses of sodium allopurinol in open-chested dogs.
    Ellis CH; Touw KB; Dickerson SW
    Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):355-67. PubMed ID: 4766552
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of intravenous ethyl alcohol on the coronary circulation and myocardial contractility of the human and canine heart.
    Mendoza LC; Hellberg K; Rickart A; Tillich G; Bing RJ
    J Clin Pharmacol New Drugs; 1971; 11(3):165-76. PubMed ID: 5211350
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacological studies of adenosine 3',5'-monophosphate and related compounds. 1. Effects of adenosine 3',5'-monophosphate and N6-2'-O-dibutyryl 3',5'-adenosine monophosphate on the renal function].
    Abe Y
    Nihon Yakurigaku Zasshi; 1969 May; 65(3):161-75. PubMed ID: 4310283
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of hexobendine on the coronary efficacy of generalized hypoxia as well as of i.cor. and i.v. single injections of adenosine in dogs].
    Raberger G; Weissel M; Kraupp O
    Arzneimittelforschung; 1973 Jun; 23(6):764-8. PubMed ID: 4740758
    [No Abstract]   [Full Text] [Related]  

  • 18. An effect of extrarenal beta adrenergic stimulation on the release of renin.
    Reid IA; Schrier RW; Earley LE
    J Clin Invest; 1972 Jul; 51(7):1861-9. PubMed ID: 4402350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N2O modification of halothane-altered renal function in the dog.
    Hill GE; Lunn JK; Hodges MR; Stanley TH; Sentker CR; Johansen R; Hatt J
    Anesth Analg; 1977; 56(5):690-5. PubMed ID: 562095
    [No Abstract]   [Full Text] [Related]  

  • 20. Some cardiac metabolic and haemodynamic alterations due to adrenergic beta-receptor blockade.
    Szekeres L; Udvary E; Papp JG
    Acta Biol Med Ger; 1972; 28(6):1031-9. PubMed ID: 4404698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.